PREPARATION OF OLIGOMERIC 2'-DEOXY-5-FLUOROURIDYLATE OF DEFINED LENGTH AND BACKBONE COMPOSITION - A NOVEL PRO-DRUG FORM OF THE POTENT ANTICANCER DRUG 2'-DEOXY-5-FLUOROURIDYLATE

被引:10
作者
GMEINER, WH
SAHASRABUDHE, P
PON, RT
SONNTAG, J
SRINIVASAN, S
IVERSEN, PL
机构
[1] UNIV NEBRASKA,MED CTR,DEPT PHARMACEUT SCI,OMAHA,NE 68198
[2] UNIV NEBRASKA,MED CTR,DEPT PHARMACOL,OMAHA,NE 68198
[3] UNIV CALGARY,REG DNA SYNTH LAB,CALGARY,AB,CANADA
来源
NUCLEOSIDES & NUCLEOTIDES | 1995年 / 14卷 / 1-2期
关键词
D O I
10.1080/15257779508014667
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A recursive protection scheme for FdUMP is employed by synthesizing oligonucleotides consisting of only FdU. 3'-O-exonuclease action releases FdUMP and a shortened oligonucleotide from which further exonuclease action releases more FdUMP. Such oligonucleotides are more cytotoxic to H4IIe, mouse fibroblast, and metastatic mouse tumor cells than are equivalent concentrations of FdU monomer.
引用
收藏
页码:243 / 253
页数:11
相关论文
共 17 条
[1]   A HOMOPOLYMER OF THE POTENT ANTI-TUMOR DRUG 2'-DEOXY-5-FLUOROURIDYLATE [J].
AMARNATH, V ;
MILLER, TL ;
BROOM, AD .
BIOCHIMICA ET BIOPHYSICA ACTA, 1983, 741 (02) :224-229
[2]   ANTI-NEOPLASTIC DRUGS - CLINICAL PHARMACOLOGY AND THERAPEUTIC USE [J].
BENDER, RA ;
ZWELLING, LA ;
DOROSHOW, JH ;
LOCKER, GY ;
HANDE, KR ;
MURINSON, DS ;
COHEN, M ;
MYERS, CE ;
CHABNER, BA .
DRUGS, 1978, 16 (01) :46-87
[3]   NON-LINEAR PHARMACOKINETIC MODELS FOR 5-FLUOROURACIL IN MAN - INTRAVENOUS AND INTRAPERITONEAL ROUTES [J].
COLLINS, JM ;
DEDRICK, RL ;
KING, FG ;
SPEYER, JL ;
MYERS, CE .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (02) :235-246
[4]   5-FLUOROURACIL BY PROTRACTED VENOUS INFUSION - A REVIEW OF RECENT CLINICAL-STUDIES [J].
HANSEN, RM .
CANCER INVESTIGATION, 1991, 9 (06) :637-642
[5]   FLUORINATED PYRIMIDINES, A NEW CLASS OF TUMOUR-INHIBITORY COMPOUNDS [J].
HEIDELBERGER, C ;
CHAUDHURI, NK ;
DANNEBERG, P ;
MOOREN, D ;
GRIESBACH, L ;
DUSCHINSKY, R ;
SCHNITZER, RJ ;
PLEVEN, E ;
SCHEINER, J .
NATURE, 1957, 179 (4561) :663-666
[6]  
HULL WE, 1988, CANCER RES, V48, P1680
[7]  
Iversen P L, 1992, Antisense Res Dev, V2, P211
[8]   THYMINELESS DEATH IN ANDROGEN-INDEPENDENT PROSTATIC-CANCER CELLS [J].
KYPRIANOU, N ;
ISAACS, JT .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 165 (01) :73-81
[9]  
LOKICH J, 1981, CANCER, V48, P2565, DOI 10.1002/1097-0142(19811215)48:12<2565::AID-CNCR2820481204>3.0.CO
[10]  
2-E